Short Interest in Check-Cap Ltd (NASDAQ:MBAI) Rises By 93.4%

Check-Cap Ltd (NASDAQ:MBAI) saw a large growth in short interest in June. As of June 15th, there was short interest totaling 127,049 shares, a growth of 93.4% from the May 31st total of 65,685 shares. Based on an average daily trading volume, of 67,215 shares, the days-to-cover ratio is currently 1.9 days. Approximately 1.8% of the company’s shares are sold short.

Check-Cap Trading Down 1.2%

NASDAQ MBAI traded down $0.01 on Wednesday, reaching $1.24. 14,070 shares of the stock traded hands, compared to its average volume of 1,308,347. The stock’s fifty day simple moving average is $1.54. The company has a market cap of $9.00 million, a P/E ratio of -0.45 and a beta of 0.59. Check-Cap has a 12 month low of $0.59 and a 12 month high of $3.92.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Check-Cap in a research report on Friday, April 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Check-Cap currently has a consensus rating of “Sell”.

About Check-Cap

Check-Cap Ltd. (NASDAQ: MBAI) is an Israel-based medical technology company focused on non-invasive screening solutions for colorectal cancer. The company develops an ingestible imaging capsule and associated detection system intended to provide a patient-friendly alternative to traditional colonoscopy and CT colonography for colorectal screening and polyp detection.

Check-Cap’s technology centers on a swallowable capsule that acquires images of the colon as it traverses the gastrointestinal tract; external detectors capture the transmitted signals and software reconstructs images for clinical review.